NCT06415643View on ClinicalTrials.gov

The Use of Islet Organoids in the Treatment of Pancreatic Surgery-related Diabetes

NARecruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 10, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
T3c Diabetes
Interventions
OTHER

Islet organoids transplantation

autologous transplantation of ex vivo expanded islet organoids.

Trial Locations (1)

Unknown

RECRUITING

Zhejiang University Second Affiliated Hospital, Hangzhou

All Listed Sponsors
collaborator

Newislet Biotechnology (Shanghai) Ltd.

UNKNOWN

lead

Zhejiang University

OTHER